Value assessment frameworks in oncology: championing concordance through shared standards

ASCO, ESMO, NHB, MCBS

The ASCO Value Framework Net Health Benefit Score (ASCO-NHB) and the ESMO Magnitude of Clinical Benefit Scale (ESMO-MCBS), introduced in 2015, are essential tools for assessing the relative benefit of cancer therapies. Both ASCO and ESMO continually refine these frameworks and engage with stakeholde…

Feb 18^th • 1 min read